LY 353381: Clinical Trials

7 completed. 4 Phase 3, 2 Phase 2, 1 Phase 4.

By phase and status

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study of Arzoxifene to Treat Korean Women With Osteoporosis arzoxifene, Placebo - Osteoporosis	Phase 2	Completed	Eli Lilly and Company	91	2008-12-01	2015-04-30
Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis Arzoxifene, Raloxifene - Osteoporosis, Postmenopausal	Phase 3	Completed	Eli Lilly and Company	320	2006-10-01	2010-01-28
Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer Arzoxifene, Placebo - Osteoporosis, Postmenopausal	Phase 3	Completed	Eli Lilly and Company	9369	2004-06-01	2010-06-02
Effects of Arzoxifene on Bone Mass and the Uterus Arzoxifene, Placebo - Postmenopausal Bone Loss	Phase 3	Completed	Eli Lilly and Company	300	2004-04-01	2007-03-09
A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment arzoxifene - Breast Cancer, Endometrial Cancer	Phase 4	Completed	Eli Lilly and Company	70	2001-01-01	2007-05-25
LY353381 in Preventing Breast Cancer in Women With Hyperplasia arzoxifene, Placebo - Breast Cancer	Phase 2	Completed	University of Kansas Medical Center	199	2000-08-01	2017-05-30
Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer. LY353381, tamoxifen - Breast Neoplasms	Phase 3	Completed	Eli Lilly and Company			2006-07-19